Caricamento...
Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond
Metastatic breast cancer remains an incurable disease, and new therapies are needed. One major limitation of chemotherapy is the toxicity associated with higher dose exposure. Antibody–drug conjugates (ADCs) are a complex and evolving class of agents specifically designed with the objective of deliv...
Salvato in:
| Pubblicato in: | BioDrugs |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933915/ https://ncbi.nlm.nih.gov/pubmed/33666903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-021-00472-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|